These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 21232670

  • 1. Vernakalant: additional evidence for safety and efficacy for new onset atrial fibrillation.
    Lindsay BD.
    J Am Coll Cardiol; 2011 Jan 18; 57(3):322-3. PubMed ID: 21232670
    [No Abstract] [Full Text] [Related]

  • 2. Intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation: systematic review and meta-analysis.
    Guerra F, Matassini MV, Scappini L, Urbinati A, Capucci A.
    Expert Rev Cardiovasc Ther; 2014 Sep 18; 12(9):1067-75. PubMed ID: 25096598
    [Abstract] [Full Text] [Related]

  • 3. A new antiarrhythmic drug in the treatment of recent-onset atrial fibrillation: vernakalant.
    Vizzardi E, Salghetti F, Bonadei I, Gelsomino S, Lorusso R, D'Aloia A, Curnis A.
    Cardiovasc Ther; 2013 Oct 18; 31(5):e55-62. PubMed ID: 23398692
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation.
    Pratt CM, Roy D, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, Retyk E, Drenning DH, Atrial Arrhythmia Conversion Trial (ACT-III) Investigators.
    Am J Cardiol; 2010 Nov 01; 106(9):1277-83. PubMed ID: 21029824
    [Abstract] [Full Text] [Related]

  • 5. 1:1 atrial flutter after vernakalant administration for atrial fibrillation cardioversion.
    de Riva-Silva M, Montero-Cabezas JM, Salgado-Aranda R, López-Gil M, Fontenla-Cerezuela A, Arribas-Ynsaurriaga F.
    Rev Esp Cardiol (Engl Ed); 2012 Nov 01; 65(11):1062-4. PubMed ID: 22727797
    [No Abstract] [Full Text] [Related]

  • 6. [Vernakalant--a new drug for pharmacological conversion of atrial fibrillation].
    Hinneburg I.
    Med Monatsschr Pharm; 2011 May 01; 34(5):154-8. PubMed ID: 21644373
    [Abstract] [Full Text] [Related]

  • 7. Is vernakalant better or not, compared with other treatments for conversion of acute atrial fibrillation?
    Conde D.
    Int J Cardiol; 2013 Oct 30; 169(2):95-6. PubMed ID: 24071384
    [Abstract] [Full Text] [Related]

  • 8. Vernakalant versus electrical cardioversion in recent-onset atrial fibrillation.
    Conde D, Lalor N, Rodriguez L, Elissamburu P, Marcelo T.
    Int J Cardiol; 2013 Oct 09; 168(4):4431-2. PubMed ID: 23890913
    [No Abstract] [Full Text] [Related]

  • 9. Vernakalant, a mixed sodium and potassium ion channel antagonist that blocks K(v)1.5 channels, for the potential treatment of atrial fibrillation.
    Billman GE.
    Curr Opin Investig Drugs; 2010 Sep 09; 11(9):1048-58. PubMed ID: 20730700
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vernakalant: pharmacology electrophysiology, safety and efficacy.
    Naccarelli GV, Wolbrette DL, Samii S, Banchs JE, Penny-Peterson E, Stevenson R, Gonzalez MD.
    Drugs Today (Barc); 2008 May 09; 44(5):325-9. PubMed ID: 18548135
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vernakalant in the management of atrial fibrillation.
    Cheng JW.
    Ann Pharmacother; 2008 Apr 09; 42(4):533-42. PubMed ID: 18334607
    [Abstract] [Full Text] [Related]

  • 15. Novel agents for the acute conversion of atrial fibrillation: focus on vernakalant.
    Cialdella P, Pedicino D, Santangeli P.
    Recent Pat Cardiovasc Drug Discov; 2011 Jan 09; 6(1):1-8. PubMed ID: 21235460
    [Abstract] [Full Text] [Related]

  • 16. Chemical cardioversion of recent-onset atrial fibrillation in the emergency department using vernakalant hydrochloride achieves safe and rapid restoration of sinus rhythm and facilitates same day discharge.
    Stoneman P, Gilligan P, Mahon P, Sheahan R.
    Ir J Med Sci; 2017 Nov 09; 186(4):903-908. PubMed ID: 28168639
    [Abstract] [Full Text] [Related]

  • 17. Vernakalant. Too dangerous in atrial fibrillation.
    Prescrire Int; 2012 May 09; 21(127):119-22. PubMed ID: 22827000
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Flecainide or propafenone vs. vernakalant for conversion of recent-onset atrial fibrillation.
    Conde D, Costabel JP, Aragon M, Caro M, Ferro A, Klein A, Trivi M, Giniger A.
    Can J Cardiol; 2013 Oct 09; 29(10):1330.e13. PubMed ID: 23465347
    [No Abstract] [Full Text] [Related]

  • 20. Effectiveness and safety of vernakalant vs flecainide for cardioversion of atrial fibrillation in the emergency department: the VERITA study.
    Dominijanni G, Caballero-Bermejo AF, Martín Jiménez ML, Calpe Delgado P, Rodríguez-Miranda B, Ruiz-Antorán B.
    Emergencias; 2024 Jun 09; 36(3):239-240. PubMed ID: 38819000
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.